NCT07486518

A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-07-01Est. Completion: 2028-04-01

Enrollment target: 4,000 participants

Locations

AIG Hospitals, Hyderabad, Telangana, India

Contact

Dr.Hardik Rughwani Dr.Hardik Rughwani, MBBS, MD, DMhardik.hr@gmail.com +91-9426928600

Other microbiome trials you might be interested in

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.Phase 1Recruiting

GEP-NETGastroenteropancreatic Neuroendocrine TumorGastroenteropancreatic Neuroendocrine Tumor DiseaseNeuroendocrine TumorsCarcinoidCarcinoid TumorPancreatic NETSolid TumorSomatostatin Receptor

The primary objectives are to determine the recommended Phase 2 dose (RP2D) and optimal treatment regimen, characterize …

Iowa City, United StatesEst. completion Feb 2027

View Trial →

A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal AdenocarcinomaPhase 2

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.